USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Unveiling One of the Most Promising Fields of Therapeutic Technology Synergy
13-Nov-2018
Global
Technology Research
D83E-01-00-00-00
HC03104-GL-TR_22527
Both predictive and prognostic biomarkers constitutes an central element in each and every targeted oncology drug discovery and development program. Breakthrough technologies allowing leveraging biomarkers for oncology are paving the way of personalized medicine and precision oncology. Indeed, oncology biomarkers provide the clinical community with the opportunity to offer individualized therapies and health programs. Furthermore, oncology biomarkers enable to get critical information about the mechanism of action of a drug or target, to profoundly study carcinogenesis process, and to match patient characteristics specifically to the most appropriate treatment.
1.1 Companion Diagnostics: The Bigger Picture
1.2 Research Focus: Advancing New Diagnostics and Therapeutics
1.3 Research Scope: Unveiling Novel Diagnostics Pathways
1.4 Analysis Framework: Frost & Sullivan’s Core Value
1.5 Research Methodology: Five Steps toward Success
2.1 Key Elements of Analysis: The ‘Companion Diagnostics’ Concept
2.2 Brief Overview of Companion Diagnostics
2.3 Effectiveness and Performance Validation for CDx
2.4 Overall Landscape of Cancer Companion Diagnostics
2.5 Precision Oncology Accelerated Pathway
2.6 Biomarker Stratification for Companion Diagnostics
2.7 Emerging Opportunities for Companion Diagnostics
3.1 Technology Synergy Reshaping Value Chain
3.2 Product Development and Commercialization
3.3 Technology and Business Landscape: Accelerators
3.4 Technology and Business Landscape: Challenges
3.5 New Approaches Driving Companion Diagnostics Solutions
4.1 Market Dynamics and Opportunities
4.2 Market Potential: Technology Focus Segmentation
4.3 Market Potential: Therapeutic Area and Regional Segmentation
4.4 Impact of Companion Diagnostics on Therapeutic Areas
4.5 Prominent Pharmaceutical Market Leaders
5.1 The Role of Stakeholders in Business Strategy
5.2 Technology Transfer Assessment and Perceptions
5.3 Disruptive Companion Diagnostics Solutions
5.4 Business Model Hybridization
5.5 Overall Environmental Impact Factors
5.6 Future Perspective for Companion Diagnostics
6.1 Key Funding and Investment Opportunities
6.2 Funding and Investment Models and Adoption
6.3 Funding Long Shots, Securitization, and Credit
6.4 Strategic Collaborations
7.1 Multicriteria Approach for Benchmarking
7.2 Strategic Portfolio Assessment
7.3 Level 1 Criteria: Innovation Development
7.4 Level 1 Criteria: Financial Performance
7.5 Level 1 Criteria: Market Evolution
7.6 Level 2 Criteria: Key Actions for Success
7.7 Analytic Performance Results
7.8 Multicriteria Final Assessment
7.9 Strategic Imperatives: Critical Success Factors
8.1 Key Industry Influencers
8.1 Key Industry Influencers (continued)
8.1 Key Industry Influencers (continued)
8.1 Key Industry Influencers (continued)
8.1 Key Industry Influencers (continued)
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
08 Oct 2026 | Global | Frost Radar
Frost Radar: Endoscopy Device Technology Ecosystem, 2026
The endoscopy device market is advancing toward higher-quality visualization and improved clinical decision-making, with innovation across 4K ultrahigh-definition display systems, image-enhanced endoscopy, and computer-aided detection systems. Advanced visualization is evolving through improvements ...
07 Oct 2026 | Global | Technology Research
Growth Opportunities in Image-Guided Cancer Ablation Systems
Image-guided cancer ablation systems are minimally invasive medical technologies that use real-time imaging to accurately guide the placement of an ablation device into a tumor, enabling localized destruction of cancerous tissue while minimizing damage to surrounding healthy structures.The increasin...
06 Oct 2026 | Global | Technology Research
Trends in Laboratory Automation, Global, 2021–2025
This research study provides a comprehensive assessment of the recent trends, technological advancements, and strategic developments shaping the global laboratory automation industry. The analysis traces the evolution of laboratory automation from task-specific automation systems to integrated, inte...
05 Oct 2026 | Global | Frost Radar
Frost Radar™: Point-of-Care Ultrasound Imaging Technology Ecosystem, 2026
The point-of-care ultrasound imaging industry is undergoing a fundamental transformation from equipment-intensive ultrasound to portable, handheld, wireless, AI-enabled, and connected point-of-care solutions. Driven by the need for rapid bedside diagnosis and decentralized healthcare delivery, speci...
25 Sep 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Diagnostic Solutions, and Implantables
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantables.The issue features advanced medical devices such as peritoneal dialysis fluid system, cold sterilization-based au...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Technology Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Cecilia Van Cauwenberghe |
| Industries | Healthcare |
| WIP Number | D83E-01-00-00-00 |
| Is Prebook | No |
| Ti Codes | D901,D910,D913,D91A,D933,D935,D936,D937,D947-TI |
Companion Diagnostics: Biomarker Platforms Enabling Precision Medicine
$4,950.00
Special Price $3,712.50 save 25 %